4//SEC Filing
Congleton Jon 4
Accession 0001933414-24-000032
CIK 0001933414other
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 5:44 PM ET
Size
8.6 KB
Accession
0001933414-24-000032
Insider Transaction Report
Form 4
Congleton Jon
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2024-06-17$12.25/sh−17,766$217,712→ 958,505 total - Sale
Common Stock
2024-06-20$11.73/sh−14,940$175,237→ 926,958 total - Sale
Common Stock
2024-06-18$11.99/sh−16,607$199,073→ 941,898 total
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 30, 2024.
- [F2]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $12.0982 to $12.4627. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.
- [F3]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $11.76 to $12.12.
- [F4]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $11.525 to $12.05.
Documents
Issuer
Mineralys Therapeutics, Inc.
CIK 0001933414
Entity typeother
Related Parties
1- filerCIK 0001644975
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 5:44 PM ET
- Size
- 8.6 KB